Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05002140
Title Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors XRad Therapeutics Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.